Skip to main content
Premium Trial:

Request an Annual Quote

Good Start Genetics, UnitedHealthcare Pen Agreement for Genetic Screening Services

NEW YORK (GenomeWeb) – Good Start Genetics has become an in-network laboratory partner for a variety of genetic screening tests under a national relationship with UnitedHealthcare, the company said today.

The agreement becomes effective Oct. 15. "We believe Good Start Genetics has set the new standard of care in genetic screening for inherited diseases, and our new relationship with UnitedHealthcare gives tens of millions more Americans access to these important carrier screening tests," Don Hardison, president and chief executive officer of Good Start Genetics, said in a statement.

Good Start Genetics offers a genetic carrier screening service called GeneVu and a preimplantation genetic screening test, EmbryVu, which both use next-generation sequencing technology. UnitedHealthcare covers more than 43 million lives.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.